The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

ViiV healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir: London Thursday ...

Eli Lilly said federal regulators have approved of a single-injection, once-monthly maintenance regimen in the U.S. for its ulcerative colitis treatment Omvoh.

Along with the boxed warning, FDA will require a statement on product labeling indicating that TXA injection is contraindicated as a neuraxial injection, and have the dose and administration section ...

Incyte (NASDAQ:INCY) and Enable Injections, Inc. (“Enable”) today announced a new partnership to develop and commercialize specific assets in Incyte’s portfolio, including its investigational, ...

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1000 women who say they developed brain tumours after taking the popular contraceptive injection Depo-Provera.